Published on 24/12/2025
Archiving EudraCT Documentation for Regulatory Inspection Readiness
Why EudraCT Archiving is Critical for Regulatory Inspections
As clinical trial inspections increasingly include scrutiny of public registry compliance, proper archiving of EudraCT documents becomes essential. Regulatory authorities such as EMA, BfArM, and national GCP inspectorates require sponsors to retain proof of EudraCT compliance—including registration confirmation, trial updates, and summary result uploads. Failing to present these documents during an audit may result in findings under EU GCP and data transparency regulations.
Documentation archived must match the data available on the public EudraCT record and serve as evidence of timely and accurate compliance. This article provides a detailed tutorial for archiving each EudraCT milestone in a GxP-compliant format.
Key Documents to Archive from the EudraCT Lifecycle
Every sponsor and clinical QA team should ensure that the following registry-related documents are archived systematically:
- Initial registration confirmation email and EudraCT number allocation
- Trial XML files with each version annotated
- EMA validation report (XML validator output)
- PDF and screenshot of the final published trial record
- End of trial declaration submission proof
- Summary results upload confirmation and public posting screenshot
Each of these files must be dated, version-controlled, and stored in a way that ensures traceability and audit readiness.
Trial_2023_000123_45_XML_v2_Validated.xml should be linked to corresponding validator output and submission confirmation.
Mapping Documents to Trial Master File (TMF) Sections
According to the TMF Reference Model (v3.2), EudraCT documents should be stored under specific zones and sections to align with ICH E6(R2) and EMA inspection practices:
| TMF Zone | Section | Document |
|---|---|---|
| Regulatory | Trial Registration | Initial EudraCT submission confirmation |
| Regulatory | Protocol Updates | Amendment update screenshots in EudraCT |
| End of Trial | Study Completion | End-of-trial declaration to Competent Authority |
| Results | Public Registry Submission | Summary results XML, confirmation, screenshots |
It is critical that each registry file is stored with appropriate indexing and metadata (e.g., date, person responsible, version).
Best Practices for Archiving Screenshots and Validator Outputs
While EudraCT doesn’t auto-generate archivable submission reports, sponsors must create their own evidence trail. The following practices ensure you meet GCP audit standards:
- Take screenshots before and after each trial status update
- Label screenshots with date and responsible person (e.g., RA_2023-07-04_EudraCT_SummaryResultUploaded.png)
- Save EMA XML validator output as a PDF or HTML file with timestamp
- Store both draft and final versions of the XML files
These files serve as digital proof of the timing, content, and validity of registry updates and will be requested by inspectors.
Archival Format and Retention Policy for EudraCT Files
To meet inspection readiness expectations, sponsors should define archival formats and retention durations in their Quality Management System (QMS). Recommended formats and durations:
- File format: XML, PDF, PNG/JPG (for screenshots), XLS (for logs)
- Retention: 25 years for trials contributing to marketing applications; 15 years for non-commercial studies
- Location: TMF (electronic or paper), backed by secure document management system (eDMS)
For institutions using CTIS going forward, the CTIS archive model complements but does not replace EudraCT archival needs for legacy studies.
Case Study: EudraCT Inspection Finding and Resolution
In 2022, an EMA inspection of a multinational oncology trial revealed a missing validator output file and no confirmation screenshot of the final summary results posting. Although the EudraCT record was publicly accessible, the lack of archived proof raised questions about submission traceability.
Corrective Action: The sponsor implemented a registry documentation checklist and conducted a retrospective review of EudraCT documentation across all open trials. Missing screenshots were recreated and validated with timestamped browser metadata. An SOP was introduced to enforce registry document retention and version control.
This case underscores that regulatory access to public EudraCT is not a substitute for sponsor-owned archival documentation during inspection.
Building a Registry Archival SOP for Compliance
A dedicated SOP on EudraCT documentation archiving should cover the following components:
- Scope: Applies to all clinical trials registered under Directive 2001/20/EC
- Responsibilities: Assign ownership to Regulatory Affairs and Clinical QA
- Process flow: Document what to archive at registration, update, and result stages
- File naming conventions and version control strategy
- Checklist templates to ensure completeness
- Review mechanism during TMF QC or pre-inspection audit
An example SOP can also include a registry compliance log to track registry activities against trial milestones. This helps demonstrate a proactive compliance culture to inspectors.
Aligning EudraCT Archival with Inspection Trends
EMA and national authorities increasingly demand not just that trials be registered and results posted, but that sponsors show documented, auditable evidence of these actions. Common inspection queries include:
- “Can you provide the timestamped validator output for the final XML upload?”
- “Show me when and who submitted the summary results.”
- “Where are the historical versions of this registry entry stored?”
Preparing these responses in advance, backed by a clean, searchable archive, is crucial for passing inspections without major or critical findings.
Conclusion
Archiving EudraCT documentation is no longer a back-office task—it is a frontline requirement for GCP compliance. Sponsors and academic institutions must ensure that all trial registration and result posting documents are version-controlled, traceable, and audit-ready. With evolving regulations, the integration of registry documents into TMF and SOPs will only become more important.
To enhance your document control system for EudraCT and CTIS transition, visit PharmaSOP.in and refer to EMA’s registry document guidance on EMA.europa.eu.